Member Price: $300.00
Title: TNP Annual Conference 2025
Description and Presenter information:
Please view the conference brochure
Release Date: October 1, 2025
Expiration Date: December 31, 2025
Courses:
F02: Geriatric Mental Health Disorder Management (1 CE, .5 RX, 1 G)
F06: Dementia Assessment with the SLUMS Test (1 CE, 1 RX, .5 G, 1 E/J)
F07: Substance Use Trends in Youth (1 CE, .5 E/J)
F08: Menopause and Cardiometabolic Wellness (1 CE, 1 RX)
F10: Stroke Impact: Care Burden and Caregiver Strain (1 CE, .5 RX, .5 G, 1 O)
F11: Pediatric Mental Health in Texas (1 CE, 1 RX)
F12: T1.5 Diabetes Mellitus and Hypercortisolism (1 CE, 1 RX, .5 G)
S13: COPD: Pathophysiology and Clinical Practice (1 CE, .5 RX, .5 G)
S16: Deprescribing Strategies for Older Adults (1 CE, 1 RX, 1 G)
S17: Congestive Heart Failure with Preserved Ejection Fraction (1 CE, .5 RX)
S19: Pediatric Vaccination and Disease Prevention (1 CE, 1 RX)
S27: Trauma-Informed Care in Clinical Practice Provider (1 CE, .25 E/J)
Accreditation:
Learners will be awarded 12 Contact Hours, including 8 RX, 4 G, 1 O, 1.75 E/J. Completion of the course and evaluation are required.
Provider Statement:
Texas Nurse Practitioners is approved as a provider of nursing continuing professional development by Louisiana State Nurses Association - Approver, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
If you are required to use an activity number or provider number on certificates, please use LSNA Provider N003232
Disclosures:
• Stephanie Hoelscher
EBSCO DynaAI AI advisory board member (compensated,
still active).
• Shelagh Larson
Organon’s NEXPLANON subdermal contraceptive device,
trainer. This will impact this talk.
Astellas’ VEOZAH non-hormonal hot flash medication,
speaker. No conflicts of interest with this talk.
• Jessica Peck
Sanofi, Speaker’s Bureau, Pediatric RSV immunization.
• Terri DeNeui
1. Spouse is the owner and CEO of a 503B manufacturing
pharmacy and a 503A compounding pharmacy (Farmakieo).
2. Speaker is the founder of a training and marketing
company with a focus on hormone replacement (EVEXIAS
Health Solutions).
All listed above will be resolved via Nurse Planner review of
presentation slides. No other relevant financial relationships exist
for presenters or planners of this conference.
